Notably, evaluated serum GDF15 levels have been reported in patients with cirrhosis (mean ± SEM: 6.51 ± 1.47 ng/mL) and HCC (mean ± SEM: 6.66 ± 0.67 ng/mL) (37). Here, GDF15 is linked to hepatocellular carcinoma.